Find a lawyer - Legal service professional:
Paul J. Pennock
Weitz & Luxenberg
New York, NY 10003
Paul J. Pennock is the Chief of the Pharmaceutical and Medical Device litigation department at Weitz & Luxenberg and the firm’s lead litigator in that area.
Litigation Leadership Roles:
Mr. Pennock is currently trying the first of what could turn out to be thousands of Fosamax femur fracture cases. Weitz & Luxenberg is taking the lead in a national litigation against Merck, the manufacturer of Fosamax, and Pennock is at the helm. Pennock has been invested in pre-trial preparations, and will now turn his attention to jury selection and Weitz & Luxenberg's evidentiary case. With hundreds of hours already devoted to the case, Pennock said plenty of hard work was still to come. "When my six-year-old says, 'I can't wait until this trial is over,' you know trials are a lot of work," Pennock said.
National Co-Lead Counsel, Actos Products Liability Steering Committee (MDL 2299); Yasmin and Yaz MDL National Plaintiffs’ Steering Committee; National Co-Lead Counsel, Seroquel National MDL Plaintiffs' Steering Committee; Liaison counsel, New York State ReNu with MoistureLoc litigation; Leading counsel, New York Bextra/Celebrex litigation; Leading counsel, New Jersey Seroquel/Risperdal litigation; Guidant Corporation National MDL Plaintiffs' Steering Committee; National Accutane Plaintiffs' Steering Committee; New Jersey Propulsid Plaintiffs' Steering Committee; Liaison Counsel for the New York State Rezulin Litigation; Liaison counsel for New York State Breast Implant Litigation; Philadelphia Baycol Litigation
Admitted: 1989, New York; 1992, U.S. District Court, Southern District of New York; 1997, U.S. District Court, Eastern District of New York; 2003, United States Supreme Court; 2005, Western District of New York; 2011, Northern District of New York
Law School: St. John's University, J.D., 1988
College: Syracuse University, B.A., 1984
Member: New York State Bar Association; New York State Trial Association; Association of Trial Lawyers of America
Born: Albany, New York, December 9, 1960
Upcoming - Speaker: AAJ Annual Convention, Getting the FDA to Act: Testimony Before the FDA and How it Impacts Consumer Safety, July 22; Litigation Strategy, July 23, 2013, Hilton, San Francisco, CA.
Speaker: Louisiana State Bar Association, 12th Annual Class Action/Complex Litigation Symposium, Where’s the Fifth Circuit on Daubert?, November 30, 2012, Ritz-Carlton Hotel, New Orleans, LA
Speaker: MTMP Presents: Actos Litigation: Winning the Cancer Case, October 11, 2012, The Bellagio Hotel, Las Vegas.
Speaker: Harris Martin’s Mass Tort Litigation Conference with Judge Marina Corodemus (Ret.), Off Label vs. Approved Labeled Representations, June 4, 2012, The Ritz-Carlton Hotel, Philadelphia, PA
Speaker: Mass Tort Strategies CLE Workshop, Actos: Act now? State & Federal Court Coordination - Criteria for Evaluating Cases, May 21, 2012, Trump International Chicago, IL
Co-Chair: MTMP Productions Presents: Actos and Pelvic Mesh Litigation. A plaintiffs only forum, February 8-9, 2012, The Ritz-Carlton Hotel, Philadelphia
Co-Chair/Speaker: Harris Martin's MDL Conference: Transvaginal Mesh and ACTOS Litigation, January 25, 2012, Miami, FL
Speaker: Pharmaceutical & Medical Device Litigation, 11th Annual Class Action/Mass Tort Symposium, Louisiana State Bar Association, December 9, 2011, New Orleans, LA.
Speaker: Actos Science, HarrisMartin's MDL Conference: Transvaginal Mesh and ACTOS Litigation, November 30, 2011, Savannah, GA
Speaker: American Association for Justice Education Yaz/Yasmin Teleseminar re: FDA/ Advisory Committee (Ad-Comm) November 10, 2011
Speaker: Mass Torts Made Perfect Presents Yaz Litigation and Emerging Torts: SSRIs, Transvaginal Mesh and Actos
Speaker: The Regulatory Story - How Yaz and Yasmin Got Approved and Actos Litigation - Overview and Analysis, Mass Torts Made Perfect Presents: YAZ and SSRI/Birth Defect Litigation, September 13, 2011, The Westin Hotel, Philadelphia.
Speaker:Mass Tort Settlements-The Ideal and the Reality, Mass Torts Judicial Forum with Hon. Marina Corodemus (Ret.), June 27, 2011, The Rittenhouse Hotel, Philadelphia
Speaker: Harris Martin Publishing, Development of the Product: Design-Through-Recall Including FDA 510k Approval and DePuy’s Promotion and Marketing of the ASR Hip, Johnson & Johnson DePuy Hip Implant Litigation Conference, November 17, 2010 - Durham, NC.
Speaker: The Case for Mass Torts, Yale Law School, November 1, 2010, New Haven, CT. Speaker, Defense Research Institute Corporate Counsel Roundtable, St. Regis Hotel, January 22, 2010, New York, NY.
Speaker, Seroquel Update, Mass Torts Made Perfect, October 15-16, 2009, Las Vegas, NV.
Lecturer, Medical Products Liability, Vioxx Liability, Brooklyn Law School, April 4, 2007
Co-Chair, Mealeys’ Vioxx Litigation Conference, December 11-12, 2006, Key Biscayne, FL
Speaker, Identifying the Emerging Areas of Pharmaceutical & Medical Device Litigation, Mealey’s Teleconference, August 17, 2006
Speaker, Contact Lens Solution Litigation, Focus on the Contact Solution Litigation, Mealey’s Teleconference, June 27, 2006
Speaker, Verdicts & Mistrials - Where Are We Now? The Impact of the First Vioxx Trials on the Future of the Litigation, Mealey’s Vioxx Litigation Conference, May 8 - 9, 2006, Amelia Island, FL
Speaker, ATLA Heart Device Litigation Group, Guidant MDL Meeting, The Unsettled J&J Takeover of Guidant, December 15, 2005, Minneapolis, MN
Speaker, Mealey’s Vioxx Litigation Conference, What’s Next? A Look to the Future in the Vioxx Litigation, December 12 - 13, 2005, Las Vegas, NV
Speaker, Mealey’s Vioxx Litigation Conference, Consolidated Proceedings, NJ Update, December 12 - 13, 2005, 2005, Las Vegas, NV
Speaker, Mealey’s Vioxx Litigation Conference, Case Evaluation: What’s New, June 22 - 23, 2005, New Orleans, LA
Speaker/Faculty Member, New York State Trial Lawyers’ Association, Federal Practice for State Practitioners, The Use of Jury Questionnaires and Motions in Limine from a Plaintiff's Perspective, April 6, 2005, New York, NY
Invitee, Conference on Electronic Discovery, February 20-21, 2004, Fordham University School of Law, New York, NY
Speaker, Mealey’s Conference on Baycol Litigation, The Non-Rhabdo Case: Disease Processes With or Without Elevated Enzyme Levels, June 2- 3, 2003, Amelia Island, FL
Speaker, The Association of the Bar of the City of New York, The Future of Expert Testimony, Science of Technical Testimony, January 30, 2003, New York, NY
Speaker, Association of Trial Lawyers Association, Baycol and its Impact on Elderly Women, October 25 - 26, 2002, Scottsdale, AZ
Speaker, Mealey’s PPA & Ephedra Litigation Conference, Medical Literature: What is Known Regarding Heart Attacks, Strokes and Psychosis, February 4 -5, 2002, Philadelphia, PA
Speaker, Association of the Bar of the City of New York, The Future of Expert Testimony, January 30, 2002, New York, NY
Speaker, Mealey’s Conference on Baycol Litigation, Theories of Liability, January 14 -15, 2002, San Diego, CA
Speaker, Mealey’s Conference on Propulsid Litigation, The "Hot" Documents and the "Key" Documents, June 14-15, 2001, New Orleans, LA
Speaker, Mealey’s Conference on Propulsid Litigation, Liability Issues Part I: The Internal Documents, January 22 - 23, 2001, New Orleans, LA
Pennock, Paul J. "Mass Tort Litigation In New York State Courts: A Practice Manual." The Plaintiff’s Personal Injury Action In New York State. Volume One. New York State Bar Association, 2009
Increased Scrutiny of Pharmaceutical Company Clinical Trials - The Plaintiff Responds. AML Law Journal Newsletters. LJN’s Product Liability Law & Strategy. Volume 25, Number 2. August 2006
Merck's Strategy for Dealing with Vioxx: Why the Old Recipes for Success Won't Succeed. AML Law Journal Newletters. LJN’s Law Journal Newsletter. June/July 2005
Paul Pennock has been quoted in the following articles:
"In the Money, and in Court--Drug Industry Braces for New Suits Over Even More of its Products," New York Times, Business section, April 22, 2006, C1 and C8.
"Inadequate Warning Suits Against AstraZeneca Pharmaceuticals Spike in Delaware Courts," The National Law Journal, May 9, 2007.
"AstraZeneca Faces 10,000 Lawsuits Over Seroquel Drug" (Update 2), Bloomberg.com, February 13, 2007.
"Scrutiny of Defibrillator Defects Grows," Trial (Association of Trial Lawyers of America), News & Trends section, August 2006, Volume 42, Issue 8.
"Update 2-Pfizer Wins Ruling that May Limit Celebrex Suits," Reuters, November 20, 2007, 11:23 a.m. EST.
Act now: It is essential that you inquire about your case as soon as possible. Litigation may be the only way to receive the damages to which you may be entitled, such as medical and health care bills, lost or diminished wages, and financial compensation to family in the case of death. Your individual state's law may limit your time to bring a legal claim to protect your rights.